Phase 3 Randomized, Controlled Study of Blinatumomab Alternating with Low-intensity Chemotherapy Versus Standard of Care for Older Adults with Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia with Safety Run-in (Golden Gate Study)

  • Fleming, Shaun (Primary Chief Investigator (PCI))
  • Cannell, Paul (Chief Investigator (CI))
  • Yeung, David T. (Chief Investigator (CI))
  • Hill, Kate (Chief Investigator (CI))
  • Bajel, Ashish (Chief Investigator (CI))
  • Bennet, Samuel (Chief Investigator (CI))
  • Greenwood, Matthew (Chief Investigator (CI))
  • Fong, Chun Yew (Chief Investigator (CI))
  • Kwan, John (Chief Investigator (CI))
  • Fedele, Pasquale (Chief Investigator (CI))
  • Watson, Anne Marie L. (Chief Investigator (CI))
  • Vanguru, Vinay (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date3/09/21 → 31/12/27

Keywords

  • Acute lymphoblastic leukaemia (ALL)
  • Chemotherapy
  • Cancer treatment
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)